2m 2m 2m 2m 2m 2m 2m
AbbVie (ABBV)
NYSE
$262.91+$2.98 (+1.15%)
Price as of Oct 02, 2026 3:22 PM EDT- $459.3BMarket Cap
- 13.29%1-Year Change
- Drug Manufacturers - GeneralIndustry
AbbVie (ABBV)
$262.91+$2.98 (+1.15%)
ABBV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $259.93 | ||
Change | -$1.66 (-0.63%) | ||
Open | $260.51 | ||
High | $262.32 | ||
Low | $259.00 | ||
Previous Close | $261.59 | ||
Volume | 3,892,077 | ||
30-Day Average Volume | 4,121,425 | ||
1-Week Change | -1.96% | ||
1-Month Change | -0.02% | ||
1-Year Change | 13.29% | ||
3-Year Change | 93.41% | ||
5-Year Change | 186.27% | ||
Fundamentals | |||
Shares Outstanding | 1.8B | ||
Total Assets | $135.1B | ||
Market Cap | $459.3B | ||
Enterprise Value | $523.6B | ||
Period: QTR TTM FY | |||
Revenue | $17.0B | ||
Net Income | $3.6B | ||
Free Cash Flow | $3.1B | ||
EBIT | $5.0B | ||
EBITDA | $6.6B | ||
Net Working Capital | -$8.0B | ||
EPS | $2.03 | ||
Enterprise Value/EBITDA | 79 | ||
Enterprise Value/Revenue | 31 | ||
P/B | -77 | ||
P/E | 128 | ||
PEG | 0 | ||
Price/Free Cash Flow | 148 | ||
Price/Operating Cash Flow | 134 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.66% | ||
Trailing Annual Dividend Yield | 2.63% | ||
Ex-Dividend Date | 10/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield